臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 711-735 of 881 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
國立臺灣大學	2016	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration	Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿
臺大學術典藏	2016	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	CHIH-HUNG HSU; Hsu C.; Guo J.-C.; Wu H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Chih-Hung Hsu;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
國家衛生研究院	2015-12	Towards an endpoint cell motility assay by a microfluidic platform	Yeh, C;Tai, W;Lin, C;Juang, D;Wu, C;Chen, Y;Hsu, C
國家衛生研究院	2015-12	A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer	Tang, ST;Liu, TW;Wen, FH;Hsu, C;Chang, YH;Chang, CS;Sung, YC;Hsieh, CI;Chang, SY;Liu, LN;Chiang, MC
國家衛生研究院	2015-11	Medical care and costs of patients with systemic lupus erythematosus in Taiwan	Cheng, J;Huang, C;Hsu, C
國家衛生研究院	2015-09	Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma	Ou, DL;Shyue, SK;Lin, LI;Feng, ZR;Liou, JY;Fan, HH;Lee, BS;Hsu, C;Cheng, AL
國家衛生研究院	2015-07	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY
國立成功大學	2015-05-01	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T.
國家衛生研究院	2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT
國家衛生研究院	2015-04	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide	Liang, PC;Ch'ang, HJ;Hsu, C;Chen, LT;Shih, TTF;Liu, TW
國家衛生研究院	2015-04	Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection	Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C
國立臺灣大學	2015	LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION	Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 許駿; 陳培哲; 陳祈玲
臺大學術典藏	2015	Magnetostriction and magnetic loss variation dependent on stress for power transformer core	Hsu, C.;Jen, S.;Liu, J.;Fu, C.;Cheng, S.; Hsu, C.; Jen, S.; Liu, J.; Fu, C.; Cheng, S.; CHAO-MING FU
臺大學術典藏	2015	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
國家衛生研究院	2014-12-15	H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis	Wu, PC;Lu, JW;Yang, JY;Lin, IH;Ou, DL;Lin, YH;Chou, KH;Huang, WF;Wang, WP;Huang, YL;Hsu, C;Lin, LI;Lin, YM;James Shen, CK;Tzeng, TY
國立交通大學	2014-12-08T15:25:22Z	Low frequency noise degradation in ultra-thin oxide (I5A) analog n-MOSFETs resulting from valence-band tunneling	Wu, JW; You, JW; Ma, HC; Cheng, CC; Hsu, C; Huang, GW; Chang, CS; Wang, T
國立成功大學	2014-11	Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma	Lin, C.; Su, W.; Lee, J.; Hsu, C.; Cheng, A.; Lin, C.; Ho, H.; Huang, C.; Hsueh, S.; Yang, J
國家衛生研究院	2014-08	Two new acidic diterpenoids from the heartwood of Pinus massoniana LAMB	Mohamed, HA;Hsieh, CL;Hsu, C;Kuo, CC;Chang, HS;Lee, CK;Lee, TH;Wu, JB;Chang, CI;Kuo, YH
國家衛生研究院	2014-07	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians	Chen, P;Takeuchi, F;Lee, JY;Li, H;Wu, JY;Liang, J;Long, J;Tabara, Y;Goodarzi, MO;Pereira, MA;Kim, YJ;Go, MJ;Stram, DO;Vithana, E;Khor, CC;Liu, J;Liao, J;Ye, X;Wang, Y;Lu, L;Young, TL;Lee, J;Thai, AC;Cheng, CY;van Dam, RM;Friedlander, Y;Heng, CK;Koh, WP;Chen, CH;Chang, LC;Pan, WH;Qi, Q;Isono, M;Zheng, W;Cai, Q;Gao, Y;Yamamoto, K;Ohnaka, K;Takayanagi, R;Kita, Y;Ueshima, H;Hsiung, CA;Cui, J;Sheu, WH;Rotter, JI;Chen, YD;Hsu, C;Okada, Y;Kubo, M;Takahashi, A;Tanaka, T;van Rooij, FJ;Ganesh, SK;Huang, J;Huang, T;Yuan, J;Hwang, JY;Gross, MD;Assimes, TL;Miki, T;Shu, XO;Qi, L;Chen, YT;Lin, X;Aung, T;Wong, TY;Teo, YY;Kim, BJ;Kato, N;Tai, ES
國家衛生研究院	2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL
國家衛生研究院	2014-06-20	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity	Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Hsu, C;Wu, MS;Tzeng, YS;Tsai, HJ;Wang, HP;Cheng, AL
國家衛生研究院	2014-06	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL
國立成功大學	2014-06	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity	Kuo, S-H; Yeh, K-H; Chen, L-T; Lin, C-W; Hsu, P-N; Hsu, C.; Wu, M-S; Tzeng, Y-S; Tsai, H-J; Wang, H-P; Cheng, A-L
國家衛生研究院	2014-04	Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis	Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology
國家衛生研究院	2014-01-03	Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin	Ou, DL;Lee, BS;Lin, LI;Liou, JY;Liao, SC;Hsu, C;Cheng, AL

Showing items 711-735 of 881 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52822145 ???header.onlineuser??? : 695 ???header.sponsordeclaration???